Jennifer L. Carter

Director, Starling Oncology, Inc.

Companies

Insight Molecular Diagnostics Inc.Board member Aug 31, 2020 to Aug 17, 2022¹
CareMax, Inc.Board member Jun 10, 2021 to Apr 5, 2022²
Starling Oncology, Inc.Board member Mar 12, 2020 to Mar 12, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Insight Molecular Diagnostics Inc. IMDX30,500 shares⁴$90.0K at $2.95Aug 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 16, 2022Bought 10,500 shares at $0.95 of Insight Molecular Diagnostics Inc.⁴
Aug 15, 2022Granted 10,000 shares of Insight Molecular Diagnostics Inc.⁴
Jun 24, 2022Exercised options 10,000 shares of Insight Molecular Diagnostics Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInsight Molecular Diagnostics Inc., Board member
2
SEC EDGARCareMax, Inc., Board member
3
SEC EDGARStarling Oncology, Inc., Board member
4
SEC EDGARInsight Molecular Diagnostics Inc. shares after the filing of Aug 16, 2022
5
SEC EDGARForm 4 filed Jul 19, 2022